We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
MHRA supports innovation in anti-cancer drug delivery by providing regulatory advice to OxSonics early on in the process.
People with diabetes who use insulin pens manufactured by Owen Mumford are today being warned by the Medicines and Healthcare products Regulatory Agency (MHRA) to check if they have an affected lot.
The Department for Transport has issued a press release calling on pharmacies to support a new year campaign to help customers understand the changes to drug driving legislation coming into force in March 2015.
Early collaboration with MHRA helps AstraZeneca to continue to supply critical cancer medicine.
A brand new facility that ensures the continued supply of a critical cancer medicine forms the basis of the first case study released from the Innovation Office today at the MHRA.
The MHRA today hosted an expert stakeholder forum to develop a future roadmap for the Yellow Card Scheme, as the adverse reaction reporting system celebrates its 50th anniversary.
The Medicines and Healthcare Products Regulatory Agency today announced the appointment of Professor Sir Michael Rawlins as its new Chair. He will take up post formally from 01 December 2014 and his appointment will be for t…
Professor Sir Michael will take over from Sir Gordon Duff from December 2014.
The Medicines and Healthcare products Regulatory Agency (MHRA) announced the UK’s biggest seizure of smart drugs, also known as cognitive enhancers or nootropics.
Regulators for the pharmaceutical manufacturing sector have pledged to reduce bureaucratic burdens on firms.
First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government
The Department of Health has today announced that three new Non-Executive Directors will join the board of the MHRA.
The Department of Health has today announced the appointment of Dr Ian Hudson as Chief Executive of the Medicines and Healthcare Products Regulatory Agency (MHRA).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).